Protara Therapeutics Stock Filter Stocks by Fundamentals
| TARA Stock | USD 2.84 0.16 5.33% |
Protara Therapeutics fundamentals help investors to digest information that contributes to Protara Therapeutics' financial success or failures. It also enables traders to predict the movement of Protara Stock. The fundamental analysis module provides a way to measure Protara Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Protara Therapeutics stock.
Protara | Shares Owned by Institutions |
Protara Therapeutics Institutional Holders
Institutional Holdings refers to the ownership stake in Protara Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Protara Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Protara Therapeutics' value.| Shares | Two Sigma Advisers, Llc | 2023-12-31 | 27 K | Two Sigma Investments Llc | 2023-12-31 | 25.1 K | Citadel Advisors Llc | 2023-09-30 | 22.1 K | Boothbay Fund Management, Llc | 2023-12-31 | 18.9 K | Northern Trust Corp | 2023-12-31 | 18.1 K | Bank Of New York Mellon Corp | 2023-12-31 | 17.9 K | Assenagon Asset Management Sa | 2023-12-31 | 15.8 K | Lpl Financial Corp | 2023-12-31 | 12 K | Millennium Management Llc | 2023-12-31 | 11.5 K | Opaleye Management Inc | 2023-12-31 | 2.7 M | Vanguard Group Inc | 2023-12-31 | 427.6 K |
Protara Fundamentals
| Return On Equity | -0.47 | ||||
| Return On Asset | -0.28 | ||||
| Current Valuation | (25.81 M) | ||||
| Shares Outstanding | 11.43 M | ||||
| Shares Owned By Insiders | 16.59 % | ||||
| Shares Owned By Institutions | 44.16 % | ||||
| Number Of Shares Shorted | 65.23 K | ||||
| Price To Book | 0.51 X | ||||
| EBITDA | (43.27 M) | ||||
| Net Income | (40.42 M) | ||||
| Cash And Equivalents | 98.46 M | ||||
| Cash Per Share | 8.74 X | ||||
| Total Debt | 5.47 M | ||||
| Debt To Equity | 0.05 % | ||||
| Current Ratio | 28.94 X | ||||
| Book Value Per Share | 6.01 X | ||||
| Cash Flow From Operations | (37.56 M) | ||||
| Short Ratio | 0.80 X | ||||
| Earnings Per Share | (3.57) X | ||||
| Target Price | 27.0 | ||||
| Number Of Employees | 26 | ||||
| Beta | 1.88 | ||||
| Market Capitalization | 34.3 M | ||||
| Total Asset | 78.95 M | ||||
| Retained Earnings | (200.38 M) | ||||
| Working Capital | 62.56 M | ||||
| Net Asset | 78.95 M |
About Protara Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Protara Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Protara Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Protara Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Protara Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Protara Therapeutics' short interest history, or implied volatility extrapolated from Protara Therapeutics options trading.
Currently Active Assets on Macroaxis
| LTC | Litecoin | |
| STETH | Staked Ether | |
| LINK | Chainlink | |
| XLM | Stellar | |
| CRO | Cronos |
Check out Protara Therapeutics Piotroski F Score and Protara Therapeutics Altman Z Score analysis. For information on how to trade Protara Stock refer to our How to Trade Protara Stock guide.You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Complementary Tools for Protara Stock analysis
When running Protara Therapeutics' price analysis, check to measure Protara Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protara Therapeutics is operating at the current time. Most of Protara Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protara Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protara Therapeutics' price. Additionally, you may evaluate how the addition of Protara Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Protara Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protara Therapeutics. If investors know Protara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protara Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.57) | Return On Assets (0.28) | Return On Equity (0.47) |
The market value of Protara Therapeutics is measured differently than its book value, which is the value of Protara that is recorded on the company's balance sheet. Investors also form their own opinion of Protara Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protara Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protara Therapeutics' market value can be influenced by many factors that don't directly affect Protara Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protara Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protara Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protara Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.